Company news
Curanex Pharmaceuticals Inc news in 2026
Curanex Pharmaceuticals Inc's news releases, calls and decks from 2026, newest first.
Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company
April 1, 2026
Curanex Provides Business Update in Connection with 2025 Annual Report as Phyto-N Advances Toward Planned IND Submission
March 29, 2026
Curanex Achieves Key Preclinical Milestone with Favorable Toxicology Profile at Maximum Dose, Advancing Toward IND Submission
March 17, 2026
Curanex Expands Scientific Advisory Board With Two Distinguished Researchers
March 11, 2026
Curanex Appoints Two Veteran Industry Leaders to Scientific Advisory Board
March 10, 2026
Curanex Forms World Class Scientific Advisory Board
March 4, 2026
Curanex Provides Operational Update on Key Regulatory Milestones
February 24, 2026